Literature DB >> 16678773

Combined loss of Cdk2 and Cdk4 results in embryonic lethality and Rb hypophosphorylation.

Cyril Berthet1, Kimberly D Klarmann, Mary Beth Hilton, Hyung Chan Suh, Jonathan R Keller, Hiroaki Kiyokawa, Philipp Kaldis.   

Abstract

Mouse knockouts of Cdk2 and Cdk4 have demonstrated that, individually, these genes are not essential for viability. To investigate whether there is functional redundancy, we have generated double knockout (DKO) mice. Cdk2-/- Cdk4-/- DKOs die during embryogenesis around E15 as a result of heart defects. We observed a gradual decrease of Retinoblastoma protein (Rb) phosphorylation and reduced expression of E2F-target genes, like Cdc2 and cyclin A2, during embryogenesis and in embryonic fibroblasts (MEFs). DKO MEFs are characterized by a decreased proliferation rate, impaired S phase entry, and premature senescence. HPV-E7-mediated inactivation of Rb restored normal expression of E2F-inducible genes, senescence, and proliferation in DKO MEFs. In contrast, loss of p27 did not rescue Cdk2-/- Cdk4-/- phenotypes. Our results demonstrate that Cdk2 and Cdk4 cooperate to phosphorylate Rb in vivo and to couple the G1/S phase transition to mitosis via E2F-dependent regulation of gene expression.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16678773     DOI: 10.1016/j.devcel.2006.03.004

Source DB:  PubMed          Journal:  Dev Cell        ISSN: 1534-5807            Impact factor:   12.270


  75 in total

Review 1.  Cell cycle molecules define a pathway required for neuron death in development and disease.

Authors:  Lloyd A Greene; David X Liu; Carol M Troy; Subhas C Biswas
Journal:  Biochim Biophys Acta       Date:  2006-12-13

Review 2.  Cardiac myocyte cell cycle control in development, disease, and regeneration.

Authors:  Preeti Ahuja; Patima Sdek; W Robb MacLellan
Journal:  Physiol Rev       Date:  2007-04       Impact factor: 37.312

3.  Hematopoiesis and thymic apoptosis are not affected by the loss of Cdk2.

Authors:  Cyril Berthet; Maria Cecilia Rodriguez-Galan; Deborah L Hodge; John Gooya; Véronique Pascal; Howard A Young; Jonathan Keller; Remy Bosselut; Philipp Kaldis
Journal:  Mol Cell Biol       Date:  2007-05-07       Impact factor: 4.272

Review 4.  Cardiac progenitors and the embryonic cell cycle.

Authors:  Sarah C Goetz; Frank L Conlon
Journal:  Cell Cycle       Date:  2007-06-13       Impact factor: 4.534

Review 5.  G1 to S phase cell cycle transition in somatic and embryonic stem cells.

Authors:  Irina Neganova; Majlinda Lako
Journal:  J Anat       Date:  2008-07       Impact factor: 2.610

6.  Epicardial control of myocardial proliferation and morphogenesis.

Authors:  Henry M Sucov; Ying Gu; Simmy Thomas; Peng Li; Mohammad Pashmforoush
Journal:  Pediatr Cardiol       Date:  2009-03-10       Impact factor: 1.655

Review 7.  Cell cycle, CDKs and cancer: a changing paradigm.

Authors:  Marcos Malumbres; Mariano Barbacid
Journal:  Nat Rev Cancer       Date:  2009-03       Impact factor: 60.716

8.  The CDK4/CDK6 inhibitor PD0332991 paradoxically stabilizes activated cyclin D3-CDK4/6 complexes.

Authors:  Sabine Paternot; Bianca Colleoni; Xavier Bisteau; Pierre P Roger
Journal:  Cell Cycle       Date:  2014       Impact factor: 4.534

9.  NFATc1 targets cyclin A in the regulation of vascular smooth muscle cell multiplication during restenosis.

Authors:  Manjula Karpurapu; Dong Wang; Nikhlesh K Singh; Quanyi Li; Gadiparthi N Rao
Journal:  J Biol Chem       Date:  2008-07-29       Impact factor: 5.157

10.  Loss of Cdk2 and cyclin A2 impairs cell proliferation and tumorigenesis.

Authors:  Lakshmi Gopinathan; Shawn Lu Wen Tan; V C Padmakumar; Vincenzo Coppola; Lino Tessarollo; Philipp Kaldis
Journal:  Cancer Res       Date:  2014-05-06       Impact factor: 12.701

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.